Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
PaperCitations, authors & open-access status
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 827 citations, 2019 year and bronze oa status.
827
Citations
2019
Year
bronze
OA Status